Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence

Ann Saudi Med. 2018 May-Jun;38(3):233-234. doi: 10.5144/0256-4947.2018.233.

Authors

Abdullah Saleh Alsultan¹, Hakeam Abdulaziz Hakeam

Affiliation

¹ Dr. Abdullah Alsultan, Clinical Pharmacy Department, College of Pharmacy, King Saud University P. O. Box 2457, Riyadh 11451,, Saudi Arabia, T: +96614677485, [email protected], ORCID: http://orcid.org/0000-0002-7013.8369.

No abstract available

Publication types

Letter

MeSH terms

Clopidogrel
Drugs, Generic / administration & dosage
Drugs, Generic / pharmacokinetics
Drugs, Generic / standards*
Humans
Platelet Aggregation Inhibitors / administration & dosage
Platelet Aggregation Inhibitors / pharmacokinetics
Platelet Aggregation Inhibitors / standards*
Safety-Based Drug Withdrawals*
Saudi Arabia
Therapeutic Equivalency
Ticlopidine / administration & dosage
Ticlopidine / analogs & derivatives*
Ticlopidine / pharmacokinetics
Ticlopidine / standards

Substances

Drugs, Generic
Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine